IO Biotech IOBTQ Cash Flow Statement (2020-2025)

OTC IOBTQ
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income (Quarter)
-2.55M-3.75M-38.36M-4.46M46.62M-17.20M-18.50M-15.69M-19.98M-17.04M-21.15M-21.68M-26.18M-19.44M-20.69M-24.01M-31.33M-22.42M-26.20M-8.38M
Depreciation and Depletion (Quarter)
0.01M0.07M0.05M0.06M0.05M0.06M0.06M0.07M0.06M0.06M0.06M0.06M0.06M
Share-based Compensation (Quarter)
0.02M0.00M0.01M0.48M1.31M1.60M1.36M2.40M1.66M1.89M1.62M2.99M1.56M1.57M1.64M1.68M1.63M1.57M7.20M5.60M
Gains from Investment Securities (Quarter)
2.59M-9.85M
Cash from Operations (Quarter)
-3.09M-3.89M-9.34M-8.17M-19.24M-20.84M-13.01M-13.35M-12.53M-14.69M-18.26M-15.99M-22.80M-24.93M-16.98M-20.81M-19.62M-23.07M-19.82M-18.48M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.10M0.40M
Amortization of Deferred Charges (Quarter)
0.22M-0.01M0.11M0.12M0.13M0.13M0.14M0.14M0.15M0.15M0.14M0.15M0.17M0.17M0.17M
Depreciation & Amortization (CF) (Quarter)
0.01M0.07M0.05M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Change in Working Capital
Change in Account Payables (Quarter)
-0.43M0.68M0.50M0.47M1.76M-1.84M2.45M-2.37M1.84M0.26M0.20M2.18M-2.77M-0.04M1.18M0.24M-0.60M0.54M0.34M0.05M
Change in Accured Expenses (Quarter)
0.37M-0.76M2.46M-0.91M3.14M-2.44M-0.41M-0.10M2.67M-0.62M0.26M-0.09M5.47M-4.65M1.49M2.08M4.00M-1.39M1.24M-1.67M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.01M0.77M-0.44M0.35M0.15M0.66M-0.59M0.11M0.01M0.78M-0.75M0.01M0.81M0.07M-0.82M
Cash from Investing Activities (Quarter)
-0.15M-0.12M-0.11M-0.12M-0.35M-0.15M-0.04M-0.02M-0.11M-0.01M-0.01M-0.01M-0.01M-0.03M-0.03M-0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
14.71M
Change in Capital Stock
Shares Issued (Quarter)
0.40M1.79M2.28M2.37M2.23M1.39M1.39M0.77M1.98M0.59M0.64M0.40M0.36M0.42M1.67M1.67M1.67M
Net Equity Issued and Repurchased (Quarter)
65.75M49.37M
Misc.
Cash from Financing Activities (Quarter)
65.41M187.54M71.87M-0.01M11.49M21.27M
Exchange Rate Effect (Quarter)
0.65M-1.70M0.87M-1.10M-1.83M-2.67M-4.66M-5.49M4.30M0.78M-0.13M-0.45M0.61M-0.27M-0.24M0.26M-0.52M0.15M-0.59M-0.26M
Change in Cash (Quarter)
-3.09M61.52M-9.34M-8.17M168.15M-20.96M-13.12M-13.47M-12.88M-14.84M-18.30M55.86M-22.92M-24.94M-16.99M-20.82M-19.64M-23.10M-8.36M2.79M
Free Cash Flow (Quarter)
-3.09M-3.89M-9.34M-8.17M-19.26M-20.85M-13.78M-12.91M-12.88M-14.84M-18.92M-15.39M-22.91M-24.94M-17.76M-20.05M-19.64M-23.88M-19.90M-17.65M
Net Cash Flow (Quarter)
-3.09M61.52M-9.34M-8.17M168.15M-20.96M-13.12M-13.47M-12.88M-14.84M-18.30M55.86M-22.92M-24.94M-16.99M-20.82M-19.64M-23.10M-8.36M2.79M